1
William L Hunter, Lindsay S Machan, A Larry Arsenault: Anti-angiogenic compositions and methods of use. Angiogenesis Technologies, Seed and Berry, February 10, 1998: US05716981 (778 worldwide citation)

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, ...


2
William L Hunter, Lindsay S Machan, A Larry Arsenault: Anti-angiogenic compositions and methods of use. Angiotech Pharmaceuticals, Seed and Berry, March 23, 1999: US05886026 (293 worldwide citation)

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, ...


3
William L Hunter, Lindsay S Machan, A Larry Arsenault: Anti-angiogenic compositions and methods of use. Angiotech Pharmaceuticals, Seed Intellectual Property Law Group PLLC, April 8, 2003: US06544544 (182 worldwide citation)

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, ...


4
William L Hunter, Lindsay S Machan: Compositions and methods for treating or preventing diseases of body passageways. Angiotech Pharmaceuticals, The University of British Columbia, Seed Intellectual Property Law Group PLLC, July 6, 2004: US06759431 (117 worldwide citation)

The present invention provides methods for treating or preventing diseases associated with body passageways, comprising the step of delivering to an external portion of the body passageway a therapeutic agent. Representative examples of therapeutic agents include anti-angiogenic factors, anti-prolif ...


5
William L Hunter, Lindsay S Machan, A Larry Arsenault: Anti-angiogenic compositions and methods of use. Angiotech Pharmaceuticals, SEED Intellectual Property Law Group PLLC, January 14, 2003: US06506411 (95 worldwide citation)

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also, provided are methods for embolizing blood vessels, ...


6
William L Hunter, Lindsay S Machan, A Larry Arsenault: Anti-angiogenic Compositions and methods for the treatment of arthritis. Angiogenesis Technologies, Seed & Berry, November 30, 1999: US05994341 (74 worldwide citation)

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, ...


7
William L Hunter, Lindsay S Machan, A Larry Arsenault: Anti-angiogenic compositions and methods of use. Angiotech Pharmaceuticals, Seed IP Law Group PLLC, January 25, 2005: US06846841 (63 worldwide citation)

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, ...


8
Lindsay S Machan, Daniel Gelbart: System for reduction of exposure to X-ray radiation. Oyen Wiggs Green & Mutala, July 19, 2011: US07983391 (6 worldwide citation)

To reduce X-ray exposure, an area of interest is selected in the image. The image of the selected area is updated frequently, comparable to rate of updates used today for the whole image. The rest of the image is updated at a significantly lower rate. Since the area of interest normally is a small p ...


9
William L Hunter, Lindsay S Machan, A Larry Arsenault: Anti-angiogenic compositions and methods of use. Seed Intellectual Property Law Group Pllc, January 2, 2003: US20030003094-A1 (2 worldwide citation)

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, ...


10
William L Hunter, Lindsay S Machan, A Larry Arsenault: Anti-angiogenic compositions and methods of use. Angiotech Pharmaceuticals, Seed Intellectual Property Law Group Pllc, January 2, 2003: US20030004209-A1 (2 worldwide citation)

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, ...